This article covers some of CHeBA's latest research.
Experts discuss the clinical importance of three new papers that support the theory that early white matter injury may be a preclinical marker for age-related cognitive decline and for Alzheimer's disease.
Read the article: White Matter Injury Found to Be Preclinical Marker for Age-related Cognitive Decline, Neurology Today (528kb, PDF)